OM1
Predict What's Next. Improve Outcomes.
Boston, United States · Founded 2015
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- om1.com
- Last Round
- Series DJul 2021
- Rounds
- 4
About
OM1 is an AI-powered real-world data platform that helps life sciences companies, healthcare providers, and payers generate evidence and predict patient outcomes. Its PhenOM foundation model, trained on over 1 billion patient-years, powers digital phenotyping, medical event prediction, and automated clinical registries. The company partners with leading pharma firms including Amgen, AbbVie, GSK, and J&J.
Summary
OM1 is an Artificial Intelligence company based in Boston, United States, founded in 2015. Its most recent funding was a Series D round in Jul 2021. Investors include Polaris Partners, Scale Venture Partners and D1 Capital Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2021
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
AI research and product company building customizable, multimodal AI systems.
Precisely is the global leader in data integrity, providing accuracy, consistency, and context in...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Palantir Technologies builds data integration and analytics platforms (Gotham and Foundry) for go...